Research status and progress of the RNA or protein biomarkers for prostate cancer
- PMID: 30962694
- PMCID: PMC6434918
- DOI: 10.2147/OTT.S194138
Research status and progress of the RNA or protein biomarkers for prostate cancer
Abstract
Prostate cancer is a kind of male malignancy. Recently, a large number of studies have reported many potential biomarkers for the diagnosis and prognosis of prostate cancer. In this literature review, we have collected a number of potential biomarkers for prostate cancer reported in the last 5 years. Among them, some are undergoing Phase III clinical trials, and others have been approved by the US Food and Drug Administration. However, most are still in the period of basic research. The review will contribute to future research to find the biomarkers to guide clinicians to make personalized treatment decisions for each prostate cancer patient.
Keywords: TMPRSS2-ERG; fusion gene; lncRNAs; methylation; microRNAs.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Similar articles
-
Prognostic Significance of TMPRSS2-ERG Fusion Gene in Prostate Cancer.Anticancer Res. 2016 Sep;36(9):4787-93. doi: 10.21873/anticanres.11037. Anticancer Res. 2016. PMID: 27630329
-
PCA3 and TMPRSS2-ERG gene fusions as diagnostic biomarkers for prostate cancer.Chin J Cancer Res. 2016 Feb;28(1):65-71. doi: 10.3978/j.issn.1000-9604.2016.01.05. Chin J Cancer Res. 2016. PMID: 27041928 Free PMC article. Review.
-
Significance of the TMPRSS2:ERG gene fusion in prostate cancer.Mol Med Rep. 2017 Oct;16(4):5450-5458. doi: 10.3892/mmr.2017.7281. Epub 2017 Aug 18. Mol Med Rep. 2017. PMID: 28849022 Free PMC article.
-
Morphological features of TMPRSS2-ERG gene fusion prostate cancer.J Pathol. 2007 May;212(1):91-101. doi: 10.1002/path.2154. J Pathol. 2007. PMID: 17385188
-
Urine TMPRSS2: ERG Fusion Transcript as a Biomarker for Prostate Cancer: Literature Review.Clin Genitourin Cancer. 2016 Apr;14(2):117-21. doi: 10.1016/j.clgc.2015.12.001. Epub 2015 Dec 17. Clin Genitourin Cancer. 2016. PMID: 26774207 Review.
Cited by
-
Accurate prognosis for localized prostate cancer through coherent voting networks with multi-omic and clinical data.Sci Rep. 2023 May 15;13(1):7875. doi: 10.1038/s41598-023-35023-9. Sci Rep. 2023. PMID: 37188913 Free PMC article.
-
FOXO1 and hsa-microRNA-204-5p affect the biologic behavior of MDA-MB-231 breast cancer cells.Int J Clin Exp Pathol. 2020 May 1;13(5):1146-1158. eCollection 2020. Int J Clin Exp Pathol. 2020. PMID: 32509089 Free PMC article.
-
Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up.BMC Med. 2020 Dec 1;18(1):376. doi: 10.1186/s12916-020-01834-0. BMC Med. 2020. PMID: 33256740 Free PMC article.
-
[Mass spectrometry-applications in pathology].Pathologe. 2019 Dec;40(Suppl 3):277-281. doi: 10.1007/s00292-019-00692-9. Pathologe. 2019. PMID: 31713660 Review. German.
-
Differential expression profiles of circRNAs in human prostate cancer based on chip and bioinformatic analysis.Int J Clin Exp Pathol. 2020 May 1;13(5):1045-1052. eCollection 2020. Int J Clin Exp Pathol. 2020. PMID: 32509077 Free PMC article.
References
-
- Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. - PubMed
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. - PubMed
-
- Wolf AM, Wender RC, Etzioni RB, et al. American Cancer Society Prostate Cancer Advisory Committee American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin. 2010;60(2):70–98. - PubMed
Publication types
LinkOut - more resources
Full Text Sources